Protagenic Therapeutics Stock Forecast - Accumulation Distribution

PTIX Stock  USD 0.50  0.02  3.85%   
Protagenic Stock Forecast is based on your current time horizon.
  
Inventory Turnover is likely to drop to 1.19 in 2024. Payables Turnover is likely to drop to 0.24 in 2024. Common Stock Shares Outstanding is likely to rise to about 4.6 M in 2024, despite the fact that Net Loss is likely to grow to (3.9 M).
Protagenic Therapeutics has current Accumulation Distribution of 2028.59. The accumulation distribution (A/D) indicator shows the degree to which Protagenic Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Protagenic Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Protagenic Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Protagenic Therapeutics VolatilityBacktest Protagenic TherapeuticsInformation Ratio  

Protagenic Therapeutics Trading Date Momentum

On December 13 2024 Protagenic Therapeutics was traded for  0.50  at the closing time. The top price for the day was 0.54  and the lowest listed price was  0.50 . The trading volume for the day was 27.4 K. The trading history from December 13, 2024 did not cause price change. The trading delta at closing time against the current closing price is 8.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Protagenic Therapeutics to competition

Other Forecasting Options for Protagenic Therapeutics

For every potential investor in Protagenic, whether a beginner or expert, Protagenic Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Protagenic Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Protagenic. Basic forecasting techniques help filter out the noise by identifying Protagenic Therapeutics' price trends.

Protagenic Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Protagenic Therapeutics stock to make a market-neutral strategy. Peer analysis of Protagenic Therapeutics could also be used in its relative valuation, which is a method of valuing Protagenic Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Protagenic Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Protagenic Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Protagenic Therapeutics' current price.

Protagenic Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Protagenic Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protagenic Therapeutics shares will generate the highest return on investment. By undertsting and applying Protagenic Therapeutics stock market strength indicators, traders can identify Protagenic Therapeutics entry and exit signals to maximize returns.

Protagenic Therapeutics Risk Indicators

The analysis of Protagenic Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Protagenic Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting protagenic stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.